Prevalence, Awareness, Treatment and Control of Hypertension in Adults with Chronic Kidney Disease in Turkey: Results from the CREDIT Study

Abstract

Background: In the Chronic REnal Disease In Turkey -CREDIT Study, a large populationbased study on 10,748 adults, the prevalence of chronic kidney disease (CKD) and relationship between CKD and other cardiovascular risk factors had been studied. Methods: This report presents the results of CREDIT study on the prevalence, awareness, treatment, and control of hypertension among CKD patients. Results: The prevalence and awareness of hypertension in CREDIT population was 32.7% and 48.6%, respectively. Of the patients with hypertension, 31.5.% were under treatment, and 16.4% had hypertension under control. Prevalence of CKD was 25.3% in patients with hypertension. Among CKD patients (15.7% of the CREDIT study population), 56.3% had hypertension. The prevalence of hypertension was 34.8% at stage 1, 79.8% at stage 3, and 92.3% at stage 5 CKD. Only 13.4% of patients with CKD have optimal blood pressure. Among CKD patients, 61.9% were aware of hypertension, and 44.2% were under treatment. Overall control rate of hypertension in subjects with CKD was 16.3% with the lowest rate at stage 1 (12.3%) and highest rate at stage 4 (40%). The control rate increased to 28.8% for CKD patients under treatment for hypertension. Conclusion: As a conclusion, hypertension is highly prevalent in subjects with CKD in Turkey with suboptimal awareness, treatment, and control rates. Appropriate health strategies should be implicated to improve prevention, early diagnosis, and treatment of hypertension, which is one of the leading causes of CKD.

Pain in Hemodialysis Patients

“…Literatür taraması sonucunda araştırmacılar tarafından hazırlandı (2,8,9,12,22). Form bireye sosyo-demografik özel-likler, hemodiyaliz tedavisine ilişkin değişkenler ve ağrıya yönelik sorular olmak üzere toplam 12 soruyu kapsamaktadır.…”

“…Dünyada her yıl bir milyon kişinin yaklaşık 150-200'ünde SDBY ortaya çıktığı ve önümüzdeki 10 yılda bu oranın iki kattan fazla artacağı tahmin edilmektedir. Türkiye'de Nefroloji Derneği tarafından yapılan CREDIT ça-lışmasına (2012) göre, kronik böbrek hastalığı prevelansı %15,7 olduğu; renal replasman tedavisi gerektiren SDBY nokta prevelansının ise milyon nüfus başına 816 olduğu belirtilmektedir (2).…”

“…Bu nedenle bir takım tıbbi tedavilere gereksinim duyulmaktadır (2). SDBY hastalarının tedavisinde en sık tercih edilen ve özellikle acil durumlarda hayat kurtarıcı olan Renal Replasman Tedavi (RRT) yöntemi hemodiyalizdir (HD) (3).…”

“…SDBY hastalarının tedavisinde en sık tercih edilen ve özellikle acil durumlarda hayat kurtarıcı olan Renal Replasman Tedavi (RRT) yöntemi hemodiyalizdir (HD) (3). Dünya çapında RRT alan sayısının 1.4 milyondan daha fazla olabileceği, yıllık insidansının yaklaşık %8 olduğu tahmin edilmektedir (2). HD tedavisi ile hastalığa bağlı semptomlar ortadan kalkarken fiziksel, ruhsal ya da sosyal bir takım kısıtlılıklar ve sorunlar tedavinin yan etkisi olarak karşımıza çıkmaktadır (4-6).…”

Would Anti-Hypertensive Treatment be a Risk Factor for National Health Budget of Turkey in 2023?

“…Epidemiological research in Turkey shows that the ratio of hypertensive patients was around 31.8% in early 2000s. When age dependent differences were analyzed, 36.1% of the hypertensive patients were woman and 27.5% of them were men [6].…”